Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ovarian Rejuvenation by Autologous Transplantation of Bone Marrow Derived Progenitors Cells
NCT02240342Unknown
- Sponsor
- Hospital Universitari i Politècnic La Fe
- Start
- Sep 2014
- Primary completion
- Mar 2015
- Modality
- Stem Cell Therapies
- Countries
- 1
01
Overview
Open-label, single-arm trial of ASCOT in Diminished Ovarian Reserve (DOR), sponsored by Hospital Universitari i Politècnic La Fe. Primary endpoint: Ovarian reserve at 6 months. Status: unknown.
02
Drugs
ASCOT
03
Conditions
Diminished Ovarian Reserve (DOR)
Beyond the preview
Go deeper on NCT02240342.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02240342.